Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
| Autor: | Suzuki, Hiroyoshi, Castellano, Daniel, Bono, Johann de, Sternberg, Cora N, Fizazi, Karim, Tombal, Bertrand, Wülfing, Christian, Foster, Meredith C, Ozatilgan, Ayse, Geffriaud-Ricouard, Christine, Wit, Ronald de |
|---|---|
| Zdroj: | Japanese Journal of Clinical Oncology; Aug2021, Vol. 51 Issue 8, p1287-1297, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|